Jiangsu Yingke Biological Pharmaceutical Co., Ltd
About Jiangsu Yingke Biological Pharmaceutical Co., Ltd
-
Country/Region:China
-
On CPHI since:2025
Meet us at
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
CPHI Middle East 2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
14 Dec 2026 - 16 Dec 2026
Products from Jiangsu Yingke Biological Pharmaceutical Co., Ltd (5)
-
Product Propofol Injectable Emulsion
Generic Drug Consistency Evaluation National Medical Insurance Class A National Essential Medicine 20 mL:0.2 g National approval number H20223914 -
Product Propofol Medium and Long Chain Lipid Injectable Emulsion
[Strength]20 mL:0.2 g Approval Number: National approval number H20203504 The first to Pass National Consistency Evaluation -
Product Oral preparation series
1. Sodium Picosulfate,Magnesium Oxide, and Anhydrous Citric Acid Oral Solution 2. Levofloxacin Oral Solution 3. Dimethicone Emulsion 4. Levocarnitine Oral Solution -
Product Three-Chamber Bag Series
1. 1440 mL Amino acids (17), Glucose (11%) and Lipid Injectable Emulsion 2. 1026 mL Amino acids (17), Glucose (19%) and Lipid Injectable Emulsion 3. 1000 mL Amino acids (15), Glucose (20%) and Lipid Injectable Emulsion (10%) 4. 1206 mL Amino acids (16), Glucose (13%) and Structural Lipid Injectabl... -
Product Topical preparation series
1. Lidocaine and Prilocaine Cream 2. Amorolfine Hydrochloride Cream 3. Mupirocin Ointment 4. Amorolfine Hydrochloride Liniment 5. Fusidic Acid Cream 6. Pimecrolimus Cream 7. Lidocaine and Tetracaine Cream


